サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463688

欧州の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別

Europe Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)

出版日
ページ情報
英文 108 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 108 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の新生児スクリーニング市場は、2022年に3億2,804万米ドルと評価され、2030年には6億5,383万米ドルに達すると予測され、2022年から2030年までのCAGRは9.0%で成長すると予測されています。

先天性疾患の負担増が欧州新生児スクリーニング市場を後押し

先天性疾患は、早期に発見して管理しなければ、生涯にわたる健康課題につながる可能性があります。これらの病気は長期的な障害の原因となり、家族、個人、ヘルスケアシステム、社会に大きな影響を与えます。WHOの推計によると、世界中で毎年24万人の新生児が生後28日以内に先天性疾患で死亡しています。さらに17万人の子どもが、先天性疾患により生後1ヵ月から5歳の間に死亡しています。多くの先天性疾患の遺伝的基盤に対する理解が深まっていることは、これらの疾患の負担を増加させているいくつかの要因のひとつです。ゲノミクスと遺伝子検査の進歩により、医療提供者は新生児におけるより広範な遺伝子変異や病態を特定できるようになった。この知識の拡大により、タイムリーな介入と治療を開始するための新生児スクリーニングによる早期診断の重要性が浮き彫りになっています。

母親の年齢、環境暴露、生活習慣の変化などの人口動態の変化は、新生児の先天性疾患のリスクを増大させる。さらに、世界人口の急増により毎日発生する出生数は増加傾向にあり、その結果、先天性疾患のリスクとなり得る新生児のプールが拡大しています。さらに、ヘルスケア・システムや政策立案者は、病気の早期発見が長期的な利益につながることを認識しています。医療制度や政策立案者は、新生児スクリーニングを日常的なヘルスケア・プロトコルや保険適用範囲に組み込むことが増えており、市場の成長をさらに刺激しています。先天性疾患の負担増は、新生児スクリーニング市場の成長を支える重要な要因です。

欧州の新生児スクリーニング市場概要

欧州の新生児スクリーニング市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。欧州の新生児スクリーニング市場の成長は、ヘルスケア支出の増加と、先天性疾患、新生児疾患、その他の新生児疾患の発生の急増によってもたらされます。医学研究で使用される技術や病気の早期発見のためのいくつかの診断スクリーニング手順の開発も、欧州の市場に利益をもたらしています。政府機関や非政府組織が母子ケアを強化するための対策を開発しているため、この地域全体で新生児スクリーニングプログラムの数は急速に増加すると予想されます。2022年のNCBIの情報によると、EUではスクリーニングが年間～4,000人の子供に恩恵をもたらすと予想されています。革新的な診断方法（MS/MSや分子技術など）の開発、治療オプション（遺伝子治療や酵素補充療法など）の開発、希少疾患に対する理解の深まりが、新生児スクリーニングプログラムの拡大を促進しています。

欧州諸国のヘルスケアプロバイダーは、より広範な遺伝・代謝疾患を網羅した包括的な新生児スクリーニングパネルを提供しています。欧州のいくつかの国のヘルスケア当局は、新生児スクリーニング・プログラムを義務化し、すべての新生児が出生直後に必須スクリーニングを受けられるようにしています。2023年にNCBIが発表したデータによると、脊髄性筋萎縮症と重症複合免疫不全症（SCID）のスクリーニングは急速に発展しており、ノルウェー、ドイツ、その他の欧州諸国は、2021年と2022年以降、国のスクリーニングプログラムにSMAスクリーニングを含める計画を持っていました。他の多くの国では、すでに地域的なパイロットプログラムが進行中です。SCIDスクリーニングはチェコ共和国で開始されたばかりです。このような法的支援により、スクリーニング検査の全体量が増加し、スクリーニングサービスプロバイダーにとって安定した予測可能な市場が形成されました。

欧州の新生児スクリーニング市場の収益と2030年までの予測（金額）

欧州の新生児スクリーニング市場のセグメンテーション

欧州の新生児スクリーニング市場は、製品タイプ、技術、検査タイプ、エンドユーザー、国によって区分されます。

製品タイプに基づき、欧州の新生児スクリーニング市場は試薬・アッセイキットと機器に二分されます。2022年の欧州新生児スクリーニング市場シェアは試薬・アッセイキットセグメントが大きいです。試薬とアッセイキットのセグメントは、DNAベースのアッセイ、免疫アッセイと酵素アッセイに細分化されます。機器セグメントは、新生児障害スクリーニング機器、パルスオキシメーター、新生児聴覚スクリーニング機器、その他の機器に細分化されます。

技術面では、欧州の新生児スクリーニング市場はタンデム質量分析（TMS）、分子アッセイ、免疫アッセイと酵素アッセイ、パルスオキシメトリースクリーニング技術、その他の技術に分類されます。パルスオキシメトリースクリーニング技術セグメントは、2022年に最大の欧州新生児スクリーニング市場シェアを占めました。

検査タイプに基づき、欧州の新生児スクリーニング市場は、乾燥血液スポット検査、聴覚スクリーン検査、重症先天性心疾患（CCHD）検査、その他の検査タイプに分類されます。2022年には、乾燥血液スポット検査分野が欧州新生児スクリーニング市場で最大のシェアを占めました。

エンドユーザー別では、欧州の新生児スクリーニング市場は病院・診療所と診断研究所に区分されます。病院・診療所セグメントは2022年に欧州新生児スクリーニング市場シェアでより大きな割合を占めました。

国別では、欧州新生児スクリーニング市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。フランスは2022年に欧州新生児スクリーニング市場を独占しました。

Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、MRC Holland BV、Natus Medical Inc、PerkinElmer Inc、Waters Corp、Zentech SAは、欧州新生児スクリーニング市場で事業展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の新生児スクリーニング市場- 主要産業力学

  • 市場促進要因
    • 新生児スクリーニングに対する政府資金の急増
    • 先天性疾患の負担増
    • 新生児疾患の有病率の増加
  • 主な市場抑制要因
    • 新生児スクリーニングの政策と実施における統一性の欠如
  • 主な市場機会
    • 新生児の遺伝子スクリーニング
  • 今後の動向
    • スクリーニングにおける機械学習と人工知能の統合
  • 影響分析

第5章 新生児スクリーニング市場：欧州市場分析

  • 欧州の新生児スクリーニング市場の収益、2022年～2030年

第6章 欧州の新生児スクリーニング市場 - 収益と2030年までの予測：製品タイプ別

  • 市場収益シェア、2022年および2030年
  • 試薬およびアッセイキット
  • 機器

第7章 欧州の新生児スクリーニング市場 - 収益と2030年までの予測：技術別

  • 市場収益シェア、2022年および2030年
  • タンデム質量分析（TMS）
  • 分子アッセイ
  • 免疫アッセイおよび酵素アッセイ
  • パルスオキシメトリー・スクリーニング技術
  • その他の技術

第8章 欧州の新生児スクリーニング市場 - 収益と2030年までの予測：検査タイプ別

  • 市場収益シェア、2022年および2030年
  • 乾燥血液スポット検査
  • 聴覚スクリーニング検査
  • 重症先天性心疾患（CCHD）検査
  • その他の検査タイプ

第9章 欧州の新生児スクリーニング市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院および診療所
  • 診断ラボ

第10章 欧州の新生児スクリーニング市場：国別分析

  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第11章 欧州の新生児スクリーニング市場-業界情勢

  • 新生児スクリーニング市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Zentech SA
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • MRC Holland BV
  • Medtronic Plc

第13章 付録

図表

List Of Tables

  • Table 1. Europe Newborn Screening Market Segmentation
  • Table 2. Europe Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Europe Newborn Screening Market Segmentation, By Country
  • Figure 2. Europe Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market
目次
Product Code: BMIRE00029604

The Europe newborn screening market was valued at US$ 328.04 million in 2022 and is expected to reach US$ 653.83 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.

Rising Burden of Congenital Diseases Fuels the Europe Newborn Screening Market.

Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the age of 1 month and 5 years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Advancements in genomics and genetic testing have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.

Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the growth of the newborn screening market.

Europe Newborn Screening Market Overview

The European newborn screening market is segmented into Germany, the UK, France, Italy, Spain , and the Rest of Europe. Growth of the newborn screening market in Europe is driven by increased healthcare spending and an upsurge in the occurrence of congenital diseases, neonatal diseases, and other newborn diseases. Developments in techniques employed in medical research and several diagnostic screening procedures for the early detection of illnesses are also benefiting the market in Europe. The number of newborn screening programs across the region is expected to increase rapidly as government and nongovernment organizations are developing measures to enhance mother-childcare. According to information by NCBI in 2022, screening is anticipated to benefit ~4,000 children annually in the EU. The development of innovative diagnostic methods (such as MS/MS and molecular technologies), therapeutic options (such as gene therapy and enzyme replacement therapies), and increased understanding of rare diseases are driving the expansion of newborn screening programs.

Healthcare providers in European countries are offering comprehensive newborn screening panels, encompassing a broader spectrum of genetic and metabolic conditions. Healthcare authorities in several European countries have implemented mandatory newborn screening programs, ensuring every newborn undergoes essential screenings shortly after birth. As per a data published by NCBI in 2023, both spinal muscular atrophy and severe combined immunodeficiency (SCID) screening are evolving quickly; Norway, Germany, and other European countries had plans to include SMA screening in their national screening programs from 2021 and 2022 onward. Regional pilot programs are already underway in many other nations. SCID screening was just launched in the Czech Republic. This legislative support has increased the overall volume of screening tests and created a stable and predictable market for screening service providers.

Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Europe Newborn Screening Market Segmentation

The Europe newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Europe newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Europe newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Europe newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Europe newborn screening market share in 2022.

Based on test type, the Europe newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Europe newborn screening market share in 2022.

By end user, the Europe newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Europe newborn screening market share in 2022.

By country, the Europe newborn screening market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe newborn screening market in 2022.

Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, MRC Holland BV, Natus Medical Inc, PerkinElmer Inc, Waters Corp, and Zentech SA are some of the leading companies operating in the Europe newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Europe Market Analysis

  • 5.1 Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Europe Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Europe Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Newborn Screening Market - Country Analysis

  • 10.1 Europe Newborn Screening Market
    • 10.1.1 Europe Newborn Screening Market, by Country
      • 10.1.1.1 UK
        • 10.1.1.1.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 France
        • 10.1.1.3.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Europe Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zentech SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 PerkinElmer Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Waters Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Masimo Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Natus Medical Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 MRC Holland BV
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms